PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 10901311-14 2000 The MOS/ADR1 cells were found to exhibit cross-resistance only to substrates for P-glycoprotein (such as doxorubicin, vincristine, and etoposide), whereas the MOS/IR1 cells were resistant to all of the drugs studied (including cisplatin and methotrexate). Vincristine 118-129 Moloney sarcoma oncogene Mus musculus 4-7 8613443-10 1996 Dose survival studies with use of a tetrazolium colorimetric assay showed that the MOS/ADR1 cells were cross-resistant to vincristine, vinblastine, etoposide, bleomycin, mitomycin C, and actinomycin D but not to dacarbazine, cisplatin, carboplatin, cytosine arabinoside, carmustine, cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil. Vincristine 122-133 Moloney sarcoma oncogene Mus musculus 83-86